Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
ATAI Life Sciences Analyst Ratings and Price Targets | NASDAQ:ATAI | Benzinga
ATAI Life Sciences NV has a consensus price target of $11.29 based on the ratings of 8 analysts. The high is $18 issued by Loop Capital on November 1, 2022. The low is $6 issued by Maxim Group on April 3, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 20, 2025, March 19, 2025, and February 13, 2025, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 423.56% upside for ATAI Life Sciences NV from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Canaccord Genuity
Maxim Group
EF Hutton
Credit Suisse
1calculated from analyst ratings
Analyst Ratings for ATAI Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/20/2025 | Buy Now | 423.56% | HC Wainwright & Co. | Patrick Trucchio52% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2025 | Buy Now | 423.56% | HC Wainwright & Co. | Patrick Trucchio52% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | Buy Now | 423.56% | HC Wainwright & Co. | Patrick Trucchio52% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 01/29/2025 | Buy Now | 423.56% | HC Wainwright & Co. | Patrick Trucchio52% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 01/28/2025 | Buy Now | 423.56% | HC Wainwright & Co. | Patrick Trucchio52% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 11/18/2024 | Buy Now | 423.56% | HC Wainwright & Co. | Patrick Trucchio52% | $15 → $10 | Maintains | Buy | Get Alert |
| 11/18/2024 | Buy Now | 475.92% | Canaccord Genuity | Sumant Kulkarni46% | $11 → $11 | Maintains | Buy | Get Alert |
| 08/30/2024 | Buy Now | 685.34% | HC Wainwright & Co. | Patrick Trucchio52% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2024 | Buy Now | 685.34% | HC Wainwright & Co. | Patrick Trucchio52% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan73% | — | Reiterates | → Overweight | Get Alert |
| 05/17/2024 | Buy Now | 685.34% | HC Wainwright & Co. | Patrick Trucchio52% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 04/04/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan73% | — | Reiterates | → Overweight | Get Alert |
| 04/03/2024 | Buy Now | 214.14% | Maxim Group | Jason McCarthy44% | → $6 | Upgrade | Hold → Buy | Get Alert |
| 04/03/2024 | Buy Now | 685.34% | HC Wainwright & Co. | Patrick Trucchio52% | $20 → $15 | Maintains | Buy | Get Alert |
| 03/27/2024 | Buy Now | 947.12% | HC Wainwright & Co. | Patrick Trucchio52% | $20 → $20 | Maintains | Buy | Get Alert |
| 01/04/2024 | Buy Now | 947.12% | HC Wainwright & Co. | Patrick Trucchio52% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 01/02/2024 | Buy Now | 947.12% | HC Wainwright & Co. | Patrick Trucchio52% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | Buy Now | 947.12% | HC Wainwright & Co. | Patrick Trucchio52% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | Buy Now | 685.34% | EF Hutton | Elemer Piros27% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 07/10/2023 | Buy Now | 947.12% | HC Wainwright & Co. | Patrick Trucchio52% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | 685.34% | EF Hutton | Elemer Piros27% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2023 | Buy Now | 947.12% | HC Wainwright & Co. | Patrick Trucchio52% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | Buy Now | 371.2% | Credit Suisse | Judah Frommer65% | → $9 | Reiterates | Outperform → Outperform | Get Alert |
| 03/31/2023 | Buy Now | 685.34% | EF Hutton | Elemer Piros27% | $15 → $15 | Reiterates | → Buy | Get Alert |
| 03/27/2023 | Buy Now | 685.34% | EF Hutton | Elemer Piros27% | $15 → $15 | Reiterates | → Buy | Get Alert |
| 03/27/2023 | Buy Now | 371.2% | Credit Suisse | Judah Frommer65% | → $9 | Reiterates | → Outperform | Get Alert |
| 03/07/2023 | Buy Now | 685.34% | EF Hutton | Elemer Piros27% | $15 → $15 | Reiterates | → Buy | Get Alert |
| 03/07/2023 | Buy Now | 371.2% | Credit Suisse | Judah Frommer65% | $11 → $9 | Maintains | Outperform | Get Alert |
| 01/19/2023 | Buy Now | 947.12% | HC Wainwright & Co. | Patrick Trucchio52% | $50 → $20 | Maintains | Buy | Get Alert |
| 01/09/2023 | Buy Now | 423.56% | Citigroup | Neena Bitritto-Garg41% | $20 → $10 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | 685.34% | EF Hutton | Elemer Piros27% | $23 → $15 | Maintains | Buy | Get Alert |
| 12/16/2022 | Buy Now | 1104.19% | EF Hutton | Elemer Piros27% | → $23 | Initiates | → Buy | Get Alert |
| 11/01/2022 | Buy Now | 842.41% | Loop Capital | Esther Hong22% | → $18 | Initiates | → Buy | Get Alert |
| 09/01/2022 | Buy Now | 947.12% | Citigroup | Neena Bitritto-Garg41% | $22 → $20 | Maintains | Buy | Get Alert |
FAQ
What is the target price for ATAI Life Sciences (ATAI) stock?
The latest price target for ATAI Life Sciences (NASDAQ:ATAI) was reported by HC Wainwright & Co. on May 20, 2025. The analyst firm set a price target for $10.00 expecting ATAI to rise to within 12 months (a possible 423.56% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ATAI Life Sciences (ATAI)?
The latest analyst rating for ATAI Life Sciences (NASDAQ:ATAI) was provided by HC Wainwright & Co., and ATAI Life Sciences reiterated their buy rating.
When was the last upgrade for ATAI Life Sciences (ATAI)?
The last upgrade for ATAI Life Sciences NV happened on April 3, 2024 when Maxim Group raised their price target to $6. Maxim Group previously had a hold for ATAI Life Sciences NV.
When was the last downgrade for ATAI Life Sciences (ATAI)?
There is no last downgrade for ATAI Life Sciences.
When is the next analyst rating going to be posted or updated for ATAI Life Sciences (ATAI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ATAI Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ATAI Life Sciences was filed on May 20, 2025 so you should expect the next rating to be made available sometime around May 20, 2026.
Is the Analyst Rating ATAI Life Sciences (ATAI) correct?
While ratings are subjective and will change, the latest ATAI Life Sciences (ATAI) rating was a reiterated with a price target of $10.00 to $10.00. The current price ATAI Life Sciences (ATAI) is trading at is $1.91, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
